Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Jinwoo Bio Co. Ltd. currently has 2 pending office actions. These actions are being reviewed by 2 distinct examiners. The portfolio shows 0 distinct art units in the current data.
THOMPSON, CAMIE S is the busiest examiner, responsible for 1 pending office action. The workload is split between the two examiners, representing a small prosecution presence.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| THOMPSON, CAMIE S | 1 | 73.8% | +10.4% |
| VAN SELL, NATHAN L | 1 | 54.5% | +24.8% |
| PHAN, DOAN THI-THUC | 1 | 42.7% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 56d |
| 18820298 | NON-WOVEN FABRIC USING HYALURONATE FIBER AND METHOD FOR MANUFACTURING SAME | VAN SELL, NATHAN L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 56d |
| 18889424 | HYALURONATE NANOFABRIC SHEET AND MANUFACTURING METHOD THEREFOR | THOMPSON, CAMIE S | — |
| 18820298 | NON-WOVEN FABRIC USING HYALURONATE FIBER AND METHOD FOR MANUFACTURING SAME | VAN SELL, NATHAN L | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18889424 | HYALURONATE NANOFABRIC SHEET AND MANUFACTURING METHOD THEREFOR | THOMPSON, CAMIE S | — | §103 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18820298 | NON-WOVEN FABRIC USING HYALURONATE FIBER AND METHOD FOR MANUFACTURING SAME | VAN SELL, NATHAN L | — | §101§103§112 | Non-Final OA | — | Pending | Aug 30, 2024 |
| 18711120 | HYALURONIC ACID FILM WITH EXCELLENT PERCUTANEOUS ABSORPTION AND MANUFACTURING METHOD THEREFOR | PHAN, DOAN THI-THUC | 1613 | §103§112Other | Final Rejection | 56d | Pending | May 17, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial